Cold chain for lyophilized peptides: moisture, not heat

Most operators new to this category assume shipping peptides is a temperature problem, and they over-rotate on ice. The more useful framing is that moisture is the primary risk to a lyophilized peptide, not heat alone.

That single correction changes how you pack, how you ship, and what you tell a customer to do when the box arrives.

Why lyophilized product is more forgiving than people think

Properly sealed lyophilized peptides ship acceptably at ambient temperature for short transit windows, on the order of five to seven days below 40°C. That is not a licence to be careless, but it does mean a two-day summer shipment is not automatically ruined.

Where it goes wrong is when transit stretches out. Longer windows mean more temperature cycling and, critically, more humidity exposure. Every cycle is an opportunity for moisture to get where it should not be.

This is why expedited two-day air is the standard choice in this category, and the reason is worth understanding precisely: it is preferred because it caps uncontrolled temperature and humidity exposure at around 72 hours, not because the product needs to arrive quickly for its own sake. You are buying a shorter exposure window, not speed.

What to actually pack

• Insulated packaging as standard. Foam-lined boxes or insulated mailers, not a bubble mailer.
• Gel packs or dry ice from roughly May through September. Seasonal, not year-round.
• A properly sealed vial. The seal is doing more work than the coolant.
• Expedited air as the default service level, with slower options treated as the exception rather than the saving.

Some compounds warrant more care regardless of season. Peptides with labile residues, cysteine, methionine, tryptophan, asparagine and glutamine, should be held at 4°C even for short periods. If your catalogue includes them, they need their own handling rule rather than the general one.

Storage, and what you can safely tell a buyer

Long-term storage requires −15°C to −20°C at minimum, with −50°C or colder preferred. Reconstituted solutions need to stay frozen below −15°C and should be aliquoted so they are not repeatedly thawed and refrozen.

There is one handling instruction that matters more than the rest and almost nobody communicates: vials must equilibrate to room temperature in a desiccator before opening. Opening a cold vial in ambient air causes condensation directly onto the product, which is the exact moisture damage the entire cold chain existed to prevent. A buyer who does the last step wrong undoes everything you spent money on.

You can put storage instructions on your product pages. Storage conditions, temperature ranges, freeze-thaw guidance, and equilibration are properties of the material.

What you cannot do is present reconstitution as a dosing protocol. Reconstitution volumes framed as preparation for use, or anything resembling a schedule, crosses from material handling into drug labeling territory, and that is the boundary the rest of your compliance posture depends on. Describe handling the compound. Do not describe using it.

Why this is a margin issue, not just a quality one

Cold-chain decisions look like a cost line until you price the alternative.

A degraded shipment produces a refund or a replacement, and often both once you factor in the second set of shipping costs. It produces a support conversation. And in the worst case it produces a chargeback, which is materially more expensive than a refund: you lose the product, the revenue, and a dispute fee, and the dispute counts toward the ratio that determines whether your processor keeps you.

That last part is the one operators miss. In a category where dispute ratios are already scrutinised and thresholds carry real fines, a packaging decision is upstream of a payments decision. The insulated mailer is cheaper than the chargeback by a wide margin.

Set it up once

The whole thing reduces to a handful of standing rules:

1. Insulated packaging on every order, no exceptions by order value.
2. Expedited air as the default service; longer transit requires a reason.
3. Seasonal coolant rule with defined start and end months, so it is not a judgment call each morning.
4. A separate, stricter rule for labile-residue compounds.
5. Storage and equilibration instructions in the box and on the product page, written as material handling.
6. A documented procedure for what happens when a shipment is delayed in transit, decided before it happens rather than during.

None of this is expensive. It is the difference between a supplier whose product arrives in the condition the certificate of analysis described, and one whose does not, which over time is most of what a research buyer is choosing between.

This guide is general information, not legal or scientific advice. Handling and storage requirements vary by compound, formulation, and supplier specification; the ranges described are published general guidance rather than product-specific instruction. Follow your supplier's documentation and consult qualified professionals for your own products.